Adimmune Corporation (4142.TW) TAI

17.70

-0.2(-1.12%)

Updated at October 20 09:33AM

Currency In TWD

Valuation

Market Cap8.47B
Enterprise Value8.72B
P/E Ratio-33.17
PEG Ratio-1.71
Price/Sales Ratio4.67
Price/Book Ratio1.58
Enterprise/Revenue5.29
Enterprise/EBITDA-112.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.14
Operating Margin-0.18

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.04

Income Statement

Revenue1.56B
Revenue/Share3.84
Gross Profit448.06M
EBITDA-84.3M
Net Income-242.75M
Diluted EPS-0.58

Balance Sheet

Total Cash1.93B
Total Cash/Share4.58
Total Debt2.87B
Total Debt/Equity0.6
Current Ratio2
Book Value Per Share11.66

Price History

52-Week Change-30.35
52-Week High27
52-Week Low15.9
Moving Average 50 Days18.18
Moving Average 200 Days19.47

Statistics

Average Volume1.39M
Shares Outstanding421.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1053:1000
Last Split DateApril 18, 2019